Clinical Trials Browser

Has results × Gastroesophageal Junction Adenocarcinoma × Paclitaxel × Clear all

NCT02898077 2022-06-14

A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Phase 3 Completed

440 enrolled 19 charts

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma